These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 12509719)
1. Cardiac phenotypes in chromosome 4q- syndrome with and without a deletion of the dHAND gene. Huang T; Lin AE; Cox GF; Golden WL; Feldman GL; Ute M; Schrander-Stumpel C; Kamisago M; Vermeulen SJ Genet Med; 2002; 4(6):464-7. PubMed ID: 12509719 [TBL] [Abstract][Full Text] [Related]
2. Human eHAND, but not dHAND, is down-regulated in cardiomyopathies. Natarajan A; Yamagishi H; Ahmad F; Li D; Roberts R; Matsuoka R; Hill S; Srivastava D J Mol Cell Cardiol; 2001 Sep; 33(9):1607-14. PubMed ID: 11549340 [TBL] [Abstract][Full Text] [Related]
3. Chromosome 4q deletion syndrome: narrowing the cardiovascular critical region to 4q32.2-q34.3. Xu W; Ahmad A; Dagenais S; Iyer RK; Innis JW Am J Med Genet A; 2012 Mar; 158A(3):635-40. PubMed ID: 22302627 [TBL] [Abstract][Full Text] [Related]
4. A GATA-dependent right ventricular enhancer controls dHAND transcription in the developing heart. McFadden DG; Charité J; Richardson JA; Srivastava D; Firulli AB; Olson EN Development; 2000 Dec; 127(24):5331-41. PubMed ID: 11076755 [TBL] [Abstract][Full Text] [Related]
5. The basic helix-loop-helix transcription factor dHAND, a marker gene for the developing human sympathetic nervous system, is expressed in both high- and low-stage neuroblastomas. Gestblom C; Grynfeld A; Ora I; Ortoft E; Larsson C; Axelson H; Sandstedt B; Cserjesi P; Olson EN; Påhlman S Lab Invest; 1999 Jan; 79(1):67-79. PubMed ID: 9952112 [TBL] [Abstract][Full Text] [Related]
6. Developmental and genetic aspects of congenital heart disease. Srivastava D Curr Opin Cardiol; 1999 May; 14(3):263-8. PubMed ID: 10358798 [TBL] [Abstract][Full Text] [Related]
7. The basic helix-loop-helix transcription factor, dHAND, is required for vascular development. Yamagishi H; Olson EN; Srivastava D J Clin Invest; 2000 Feb; 105(3):261-70. PubMed ID: 10675351 [TBL] [Abstract][Full Text] [Related]
8. Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Srivastava D; Thomas T; Lin Q; Kirby ML; Brown D; Olson EN Nat Genet; 1997 Jun; 16(2):154-60. PubMed ID: 9171826 [TBL] [Abstract][Full Text] [Related]
9. Child with velocardiofacial syndrome and del (4)(q34.2): another critical region associated with a velocardiofacial syndrome-like phenotype. Tsai CH; Van Dyke DL; Feldman GL Am J Med Genet; 1999 Feb; 82(4):336-9. PubMed ID: 10051168 [TBL] [Abstract][Full Text] [Related]
10. HAND proteins: molecular mediators of cardiac development and congenital heart disease. Srivastava D Trends Cardiovasc Med; 1999; 9(1-2):11-8. PubMed ID: 10189962 [TBL] [Abstract][Full Text] [Related]
11. Haploinsufficiency of the basic helix-loop-helix transcription factor HAND2 causes congenital heart defects. Cohen ASA; Simotas C; Webb BD; Shi H; Khan WA; Edelmann L; Scott SA; Singh R Am J Med Genet A; 2020 May; 182(5):1263-1267. PubMed ID: 32134193 [TBL] [Abstract][Full Text] [Related]
12. A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Yamagishi H; Garg V; Matsuoka R; Thomas T; Srivastava D Science; 1999 Feb; 283(5405):1158-61. PubMed ID: 10024240 [TBL] [Abstract][Full Text] [Related]
13. dHAND-Cre transgenic mice reveal specific potential functions of dHAND during craniofacial development. Ruest LB; Dager M; Yanagisawa H; Charité J; Hammer RE; Olson EN; Yanagisawa M; Clouthier DE Dev Biol; 2003 May; 257(2):263-77. PubMed ID: 12729557 [TBL] [Abstract][Full Text] [Related]
14. Targeted deletion of a branchial arch-specific enhancer reveals a role of dHAND in craniofacial development. Yanagisawa H; Clouthier DE; Richardson JA; Charité J; Olson EN Development; 2003 Mar; 130(6):1069-78. PubMed ID: 12571099 [TBL] [Abstract][Full Text] [Related]
15. Overdosage of Hand2 causes limb and heart defects in the human chromosomal disorder partial trisomy distal 4q. Tamura M; Hosoya M; Fujita M; Iida T; Amano T; Maeno A; Kataoka T; Otsuka T; Tanaka S; Tomizawa S; Shiroishi T Hum Mol Genet; 2013 Jun; 22(12):2471-81. PubMed ID: 23449628 [TBL] [Abstract][Full Text] [Related]
16. The transcription factors GATA4 and dHAND physically interact to synergistically activate cardiac gene expression through a p300-dependent mechanism. Dai YS; Cserjesi P; Markham BE; Molkentin JD J Biol Chem; 2002 Jul; 277(27):24390-8. PubMed ID: 11994297 [TBL] [Abstract][Full Text] [Related]
17. Cooperative interaction between the basic helix-loop-helix transcription factor dHAND and myocyte enhancer factor 2C regulates myocardial gene expression. Zang MX; Li Y; Wang H; Wang JB; Jia HT J Biol Chem; 2004 Dec; 279(52):54258-63. PubMed ID: 15485823 [TBL] [Abstract][Full Text] [Related]
18. Anatomic patterns of conotruncal defects associated with deletion 22q11. Marino B; Digilio MC; Toscano A; Anaclerio S; Giannotti A; Feltri C; de Ioris MA; Angioni A; Dallapiccola B Genet Med; 2001; 3(1):45-8. PubMed ID: 11339377 [TBL] [Abstract][Full Text] [Related]
19. GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23.1 and congenital heart disease. Pehlivan T; Pober BR; Brueckner M; Garrett S; Slaugh R; Van Rheeden R; Wilson DB; Watson MS; Hing AV Am J Med Genet; 1999 Mar; 83(3):201-6. PubMed ID: 10096597 [TBL] [Abstract][Full Text] [Related]
20. Akt-dependent phosphorylation negatively regulates the transcriptional activity of dHAND by inhibiting the DNA binding activity. Murakami M; Kataoka K; Fukuhara S; Nakagawa O; Kurihara H Eur J Biochem; 2004 Aug; 271(16):3330-9. PubMed ID: 15291810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]